Snowball logo
logo
0994

BioPlus Co. Ltd.

099430 KQ
3,610.000.00  (0%)
Estimate
Beta
0.594
Growth
Revenue, YoY
15.35%
Net income, YoY
-13.07%
FCF, YoY
119.86%
Dividends
Dividend yield
1.94%
Annual payout
70.00
Next ex. div date
December 29, 26
Dividend growth streak
1 year
Div.rating
About the company
Ticker
099430
ISIN
Country
South Korea
Sector (GICS)
Healthcare
Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus " Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.

Frequently asked questions

What sector does BioPlus Co. Ltd. (099430) operate in?

BioPlus Co. Ltd. belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is BioPlus Co. Ltd. (099430) current stock price?

As of the latest data, BioPlus Co. Ltd. stock price is ₩3,610, with a previous close of ₩3,610.

What is BioPlus Co. Ltd. (099430) current market capitalization?

BioPlus Co. Ltd. market cap is approximately 222.16 billion.

Does BioPlus Co. Ltd. (099430) pay dividends?

Yes. BioPlus Co. Ltd. pays annual dividends with an annualized yield of 1.94% and an estimated annual payout of ₩70 per share.

When is the next ex-dividend date for BioPlus Co. Ltd. (099430)?

The next ex-dividend date is scheduled for December 29, 2026.

What is BioPlus Co. Ltd. (099430) beta (volatility) score?

BioPlus Co. Ltd. has a beta of 0.594, indicating lower volatility than the overall market.